[Federal Register Volume 84, Number 204 (Tuesday, October 22, 2019)]
[Notices]
[Pages 56456-56457]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-22980]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, Office of Infectious Diseases 
(BSC, OID)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting for the Board of Scientific Counselors, 
Office of Infectious Diseases (BSC, OID). This meeting is open to the 
public, limited only by the space available; the meeting room will 
accommodate up to 100 people. The public is also welcome to listen to 
the meeting by telephone, limited only by the number of ports available 
(100); the toll-free dial-in number is 1-877-951-7311, with a pass code 
of 5421098.

DATES: The meeting will be held on December 4, 2019, 12:30 p.m. to 5:30 
p.m., EST, and December 5, 2019, 8:30 a.m. to 3:30 p.m., EST.

ADDRESSES: CDC, Global Communications Center, 1600 Clifton Road NE, 
Building 19, Auditorium B3, Atlanta, Georgia 30329-4027; also 1-877-
951-7311, with a pass code of 5421098.

FOR FURTHER INFORMATION CONTACT: Sarah Wiley, MPH, Designated Federal 
Officer, CDC, 1600 Clifton Road NE, Mailstop H24-12, Atlanta, Georgia 
30329-4027, Telephone (404) 639-4840; [email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The BSC, OID, provides advice and guidance to the 
Secretary, Department of Health and Human Services; the Director and 
the Deputy Director for Infectious Diseases (DDID), CDC; and the 
Directors of the National Center for Emerging and Zoonotic Infectious 
Diseases, the National Center for HIV/AIDS, Viral Hepatitis, STD, and 
TB Prevention, and the National Center for Immunization and Respiratory 
Diseases, CDC, in the following areas: Strategies, goals, and 
priorities for programs; research within the national centers; and 
overall strategic direction and focus of DDID and the national centers.
    Matters To Be Considered: The agenda will include updates on CDC 
activities from CDC's Deputy Director for Infectious Diseases along 
with focused discussions on recent outbreaks and affected populations 
and on vector-borne diseases. Reports back from four workgroups will 
also be given: (1) The Board's Acute Flaccid Myelitis (AFM) Task Force; 
(2) the Board's Food Safety Modernization Act Surveillance Working 
Group; (3) the Board's Infectious Diseases Laboratory Working Group; 
and (4) the Vector-borne Diseases Workgroup of the BSC, OID, and the 
Board of Scientific Counselors, National Center for Environmental 
Health/Agency for Toxic Substances and Disease Registry. Agenda items 
are subject to change as priorities dictate.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and

[[Page 56457]]

Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-22980 Filed 10-21-19; 8:45 am]
 BILLING CODE 4163-18-P